Lightnews — Scholar-powered news

Medthority @medthority.bsky.social · 51m

#PeDRA2025 starts today! Catch up on the latest in #dermatology with our extensive resources across a range of conditions, from childhood psoriasis to chronic spontaneous urticaria #MedSky #DermSky

ow.ly/FMkE50X9fgu

1 1

Medthority @medthority.bsky.social · 6h

How can you help mitigate disparities in #alopecia areata care for skin of color populations? Register now to join our live, accredited webinar on October 21st at 12:00 EST with Antonella Tosti, Arash Mostaghimi, Kristen Lo Sicco, and Loren Krueger #MedSky #CME #DermSky

https://ow.ly/XGgI50X90OT

1 1

Medthority @medthority.bsky.social · 1d

Can secondary HLH/MAS be caught before it escalates? Join Fabrizio De Benedetti in our NEW CME-accredited module, “Secondary HLH/MAS Masterclass,” as he unpacks the diagnostic puzzle and explores evolving treatment pathways to improve outcomes #MedSky #CME

ow.ly/p1qf50X8yR9

Medthority @medthority.bsky.social · 2d

📰It’s news-day Tuesday! New trial data suggest cannabis outperforms opioids for lower back pain, while a dietary intervention may help heal intestinal damage from radiation or chemotherapy. Read the #news you need to know now, over on Medthority #MedSky #MedicalNews

ow.ly/H3si50X7U2x

1 1

Medthority @medthority.bsky.social · 2d

From new approaches in alopecia areata (AA) assessment to emerging agents for hidradenitis suppurativa (HS), catch up on the insights you might have missed at this year’s #EADVCongress with our NEW highlights #MedSky #DermSky #EADV2025

ow.ly/bbzF50X7RSf

1 1

Medthority @medthority.bsky.social · 2d

Can early cystoscopy improve #NMIBC survival? A recent nationwide study suggests yes, with a 42% lower risk of all-cause mortality within 6 months of TURBT. Read our latest news article now for more information, including subgroup analysis and limitations #MedSky #Oncology

ow.ly/OlGn50X5uiW

1 1

Medthority @medthority.bsky.social · 6d

#UEGWeek kicks off this weekend! Stay up to date on the latest insights in gastroenterology with this accredited symposium on #AATD. Earn #CME credit now with expert advice on implementing multidisciplinary care and emerging therapies

#MedSky #UEGWeek2025

ow.ly/aWtY50X5uhg

1 1

Medthority @medthority.bsky.social · 7d

Watch Gregory Piazza and Rohan Wijesurendra share their key takeaways from this year’s #ESCCongress, focusing on navigating bleeding risk in patients with provoked VTE and the future of asymptomatic AF screening and diagnosis #MedSky #CardioSky #ESCCongress2025 #WCCardio

ow.ly/snbI50X5G6T

1 1

Medthority @medthority.bsky.social · 7d

October is #BreastCancerAwarenessMonth! Get closer to the conversations that matter in breast cancer care with congress highlights and the latest news and guidelines, free and on demand with Medthority #MedSky #Oncology #BreastCancer

ow.ly/Houx50X5qec

1 1

Medthority @medthority.bsky.social · 9d

How does AATD impact pulmonary health? This #InternationalPodcastDay, tune in to episode 1 of ‘Understanding AATD’ to hear Pavel Strnad and Marc Miravitlles explore this rare disease’s pulmonary impact, from comorbidities to delayed diagnosis #MedSky #LiverSky #CME

ow.ly/YRXt50X4lUh

1 2

Medthority @medthority.bsky.social · 10d

How are thymidine kinase 2 deficiency (TK2d) care strategies evolving? Michio Hirano shares the latest updates on managing TK2d, from early symptom care to emerging disease-modifying therapies, in this accredited on-demand symposium from #EPNS2025 #MedSky #NeuroSky

ow.ly/sagZ50X3w58

1 1

Medthority @medthority.bsky.social · 13d

Is precision medicine redefining #mCRPC care? Visit Medthority now for more on treatment options, their clinical implications, and meeting unmet needs #ProstateCancerAwarenessMonth #ProstateCancer #UrologyAwarenessMonth #MedSky

https://ow.ly/NHSj50X2IWT

1 1

Medthority @medthority.bsky.social · 14d

What is Fred Witjes’ top tip for reassuring patients with #NMIBC about life after cystectomy? Listen to Witjes and @ashishkamatmd.bsky.social share practical strategies for supporting older, frailer patients through treatment in our expert podcast series #MedSky #Oncology

ow.ly/wsCV50X2a7T

1 2

Medthority @medthority.bsky.social · 15d

Get the latest medical news and updates you need to know, straight to your inbox. Visit our news page or sign up for our regular newsletter, making it even easier to stay up to date #MedSky #MedEd #MedicalNews

ow.ly/5K4n50X1AOs

1 1

Medthority @medthority.bsky.social · 16d

What are the key takeaways in #CSU management from #EADVCongress? Catch-up on the updates you need to know, from clinical outcomes in key trials to comparative insights on advanced therapies, with our short summary articles available now #MedSky #EADV2025 #DermSky

ow.ly/P2cf50X0VnN

1 1

Medthority @medthority.bsky.social · 17d

NEW episode: Which studies presented at #ESCCongress showed practice-changing results in thrombosis management? Listen to @gbarnesmd.bsky.social and @mproiettimd.bsky.social discuss the updates you need to know on venous thromboembolism and atrial fibrillation #MedSky #ESC2025

ow.ly/VPOt50X0iuz